key: cord-0818142-o3hgz3xg
authors: Truong, Tiffany; Dittmar, Michael; Ghaffari, Arshia; Lin, Eugene
title: Policy and Pandemic: The Changing Practice of Nephrology During the COVID-19 Outbreak
date: 2020-06-24
journal: Adv Chronic Kidney Dis
DOI: 10.1053/j.ackd.2020.06.003
sha: fa3c6bd17a29957056a2ea9d330a1c2c8bd34ef2
doc_id: 818142
cord_uid: o3hgz3xg

ABSTRACT The coronavirus (COVID-19) pandemic has changed care delivery for patients with end-stage kidney disease (ESKD). We explore the United States healthcare system as it pertains to dialysis care, including existing policies, modifications implemented in response to the COVID-19 crisis, and possible next steps for policy makers and nephrologists. This includes policies related to resource management, use of telemedicine, prioritization of dialysis access procedures, expansion of home dialysis modalities, administrative duties, and quality assessment. The government has already established policies that have instated some flexibilities to help providers focus their response to the crisis. However, future policy during and following the COVID-19 pandemic can bolster our ability to optimize care for patients with ESKD. Key themes in this perspective are the importance of policy flexibility, clear strategies for emergency preparedness, and robust health systems that maximize accessibility and patient autonomy.

The coronavirus 2019 (COVID-19) pandemic has disproportionately affected older patients with comorbidities [1] [2] [3] . Patients with end-stage kidney disease (ESKD) are particularly vulnerable. Some studies report mortality rates as high as 13% in the hemodialysis population 4 .

The first reported death from COVID-19 in the United States was a patient receiving hemodialysis in Seattle, Washington 5 . In response, the dialysis organization rapidly established education, screening, and testing protocols to safely cohort and dialyze patients. Managing a complex and vulnerable dialysis population amidst a rapidly evolving crisis requires a nimble response. Federal policy, then, plays a critical role in alleviating the difficulties faced by nephrologists and dialysis facilities whose attentions are monopolized by the pandemic. In this perspective, we summarize new policies shaping ESKD care during the COVID-19 pandemic, propose next steps for policy makers and the nephrology provider community, and speculate on the impact of these policies on nephrology care after the COVID-19 pandemic.

Healthcare facilities in the United States rarely contend with resource scarcity on the scale seen during the COVID-19 pandemic. The nephrology community has had to address shortages of continuous renal replacement therapy (CRRT) solutions, dialysis machines, staffing, and personal protective equipment (PPE) [6] [7] [8] . Shortages of CRRT dialysate and dialysis machines have anecdotally led to increased use of intermittent hemodialysis instead of CRRT, shortened treatment times, and rationing of dialysis altogether. To address these challenges, the Centers for Medicare and Medicaid Services (CMS) has been working closely with the U.S.

Food and Drug Administration (FDA) to increase dialysate manufacturing and strengthen supply chains 9 .

The Centers for Disease Control and Prevention (CDC) has also released recommendations on strategies to mitigate staffing shortages. These include outlining contingency and crisis strategies, considering alternate care sites (including "siloing") for treating patients with COVID-19, and implementing return to work criteria for providers contracting the virus [10] [11] [12] . Identifying effective strategies to optimize staffing is particularly important in dialysis care, as nurses are highly specialized, have high exposure risk, and work with a vulnerable population that requires frequent, routine care. Staffing shortages would significantly cut a medical facility's ability to dialyze patients both in the inpatient and outpatient settings. Finally, the CDC has released guidelines for optimizing PPE use, including distributing stockpiled N95 respirators, purchasing PPE from other countries, decontaminating N95 respirators for reuse, and creating a PPE burn rate calculator 13 . N95 respirator decontamination techniques-ultraviolet irradiation, microwave-generated steam, warm moist heat, and hydrogen peroxide vapor-were extensively studied in anticipation of an influenza pandemic and implementation of these techniques has materially relieved PPE shortages in hard hit COVID-19 areas [14] [15] [16] [17] [18] .

Telemedicine offers the advantage of continuity of care without person-to-person contact. While rudimentary infrastructure for telehealth existed in large health systems even before the pandemic, the use of telehealth has dramatically increased following CMS' decision to waive onerous requirements restricting its use 19 . Previously, only patients using home dialysis modalities had the ability to use telemedicine, and only with approved, encrypted devices and software 20, 21 . CMS relaxed requirements for telemedicine requiring both audio and visual inputs as dictated by the Coronavirus Aid, Relief, and Economic Security (CARES) Act 22 . Because many patients do not have access to online video devices, this has allowed clinicians to use audio-only devices for patient encounters without taking large reimbursement cuts. CMS also removed restrictions on the types of practitioners who could bill for telemedicine encounters, expanding the scope of essential nephrology care. One robust system experienced with telemedicine and nephrology care is the Veterans Affairs (VA) health system, which has substantially increased access to care to patients living in rural areas, many of whom have chronic kidney disease 23 . The VA has over 150 medical centers serving as "hubs" for community-based outpatient clinics, which can deliver multidisciplinary care in conjunction with nutritionists, surgeons, and interventional radiologists 23 .

A long-term perspective for telemedicine would behoove policy makers. Should carecoordination improve in the status quo, CMS could consider extending waivers beyond the COVID-19 pandemic. Even prior to the pandemic, CMS proposed voluntary payment models that relaxed regulatory requirements for telehealth to promote different avenues for delivering multidisciplinary care. The nephrology provider community should aim to work alongside these efforts to train and accredit health professionals in telemedicine, which will maximize providers' likelihood of success 24 . A close monitoring effort during the pandemic could help policy makers determine whether an expanded telemedicine benefit remains appropriate after the pandemic subsides.

Reports indicate that many centers have deferred vascular access procedures including arteriovenous fistula (AVF) and arteriovenous graft (AVG) placement during the COVID-19 crisis [25] [26] [27] . While early delays may have stemmed from initial CMS guidance recommending deferral of nonessential surgical procedures, delays remain widespread despite CMS' clarification that dialysis access procedures are essential 28 . Some delays may be justified, especially in areas with high COVID-19 caseloads. Hospital administrators must weigh the potential benefits of placing permanent vascular accesses earlier against the downsides of potentially exposing patients to the virus and of consuming valuable resources, including facilities, personnel, and PPE. Short-term delays of vascular access procedures may be safer for some patients. Delaying dialysis initiation until absolutely necessary is always recommend but could also help alleviate the need to place vascular accesses 29 . However, nephrologists should remain vigilant that many patients have delayed seeking urgent medical care due to COVID-19 fears, and nephrologists should not hesitate to initiate dialysis when indicated [30] [31] [32] [33] .

In regions with already low COVID-19 prevalence, transitioning from a crisismanagement stance to one that plans for eventual sequelae of delayed vascular access procedures may yield dividends. Finding safe opportunities to place permanent vascular accesses could stave off life-threatening bloodstream infections and thromboembolic complications associated with long-term dialysis catheter use [34] [35] [36] . Doing so may not be easy.

Globally, the 12-week cancellation rate for elective, non-oncologic surgeries is 82%, leading to a backlog of cases projected to take a median of 45 weeks to clear 37 . As hospitals fill operating room schedules with semi-elective and elective cases, patients undergoing hemodialysis may find it difficult to schedule a procedure. Although the American College of Surgeons has published principles for prioritizing elective procedures, operationalizing these principles in a way that is "sensitive to the institution's resources, priorities, and patient needs" remains a challenge 38 . Given large revenue shortfalls due to cancellations, hospitals may be tempted to prioritize high-revenue procedures rather than those most likely to positively improve patient outcomes, such as timely permanent dialysis access placements 39, 40 . Relieving the bottleneck will likely require a combination of policies: (i) guidance on prioritizing procedures that prevent downstream complications (i.e. AVFs to prevent line infections), (ii) additional rounds of legislative stimulus aimed at alleviating accumulating hospital debt, and (iii) potentially increasing reimbursements for fistulas and grafts. CMS and policy researchers should study whether preventing expensive bloodstream infections could offset costs from higher reimbursements.

Percutaneous AVF placements, performed endovascularly using thermal energy or radiofrequency, were approved by the FDA in 2019 41 . Because they can be performed in an office-based fluoroscopy lab, they could alleviate the mounting backlog. They can also be placed under local or regional anesthesia, avoiding aerosol-generating intubation from general anesthesia. Concomitant assessment of vasculature during the procedure could further streamline the process by obviating preparatory vascular mapping that was likely delayed during the outbreak. CMS could temporarily increase office-based reimbursements for percutaneous AVFs to incentivize their use. Because CMS does not have to reimburse for facility fees, this option could simultaneously be cheaper than routine AVFs. Caution is warranted, however.

Percutaneous AVFs are a relatively new technology, and although early results are promising, robust data on their efficacy remain limited 42 .

Home dialysis has gained appeal during the pandemic because patients can minimize their exposure to others. Additionally, peritoneal dialysis (PD) using percutaneously placed catheters can decrease the need for AVFs and AVGs and can provide another outlet for delayed vascular access procedures with the added benefit of being able to start dialysis urgently. Just prior to the COVID-19 pandemic, CMS proposed measures to expand home dialysis use through the Advancing American Kidney Health initiative, which aims to have 80% of patients with new kidney failure use a home dialysis modality or obtain a transplant by 2025 43 .

Even before the pandemic, the task of building the necessary infrastructure to drastically increase home dialysis modalities, including the training of nephrologists, nurses, and dialysis staff, was daunting. 44 Only 14% of patients with incident ESKD use a home dialysis modality or receive a transplant 45 . COVID-19 has made infrastructure investments in home dialysis substantially more challenging. Notably, the American Society of Nephrology (ASN) has created a multidisciplinary COVID-19 Home Dialysis subcommittee with representatives from the Nephrologists Transforming Dialysis Safety (NTDS) initiative, the CDC, dialysis organizations, home dialysis vendors, nurses, and patients. The subcommittee has a broad set of aims, including advocating for increased access procedures, addressing staffing shortages, exploring urgent-start PD, expanding home telehealth capabilities, and ensuring adequate supplies. 46 The steepest barrier to successfully expanding home dialysis during the COVID-19 pandemic is arguably the training, which could expose available staff to patients with COVID-19.

As CRRT solution shortages have led to increased attention toward urgent start PD, consideration should be given to increasing the capacity of staff able to support patients on For patients with acute kidney injury (AKI), acute PD may confer additional advantages when patients experience difficulties with hemodialysis or CRRT due to coagulopathies related to COVID-19 or when hemodialysis and CRRT resources have been exhausted 50 , challenges that exacerbate supply and personnel shortages in areas with high COVID-19 burden [50] [51] [52] .

Despite these potential advantages in the acute setting, Medicare currently has no payment mechanism to extend PD for acute kidney injury in the outpatient setting 53 . Policy makers at CMS and in Congress should note that promoting home dialysis infrastructure could translate into a sustained impetus for home dialysis use even after the pandemic has subsided.

To allow healthcare providers greater time and flexibility to address this national emergency, CMS has relaxed administrative burdens on providers. While some efforts preceded the COVID-19 pandemic with CMS' "Patients over Paperwork" initiative, the pandemic has accelerated these changes 48, 54 Additionally, CMS made MIPS reporting for clinicians reporting as individuals optional without any penalties. Clinicians reporting as groups could apply for an "Extreme and Uncontrollable

Circumstances" exemption, which allows qualifying groups to forego data submission. Providers participating in a COVID-19 clinical trial may now also report it as a high-weighted Improvement Activity 60 .

Similarly, CMS will not include data from the first two reporting quarters, from January 1, 2020 to June 30, 2020, for dialysis QIP reporting 61 . While high QIP performance is associated with superior patient outcomes under normal circumstances, the COVID-19 outbreak has confounded CMS' ability to reliably measure high quality care and could distract providers from responding adequately to the crisis 62 . Although QIP data from January 1, 2020, to March 1, 2020, were likely not impacted by the pandemic, CMS has indicated that providers should not focus on data reporting during the crisis. Because different regions of the country have experienced varying severities of the outbreak, standardizing quality measures across the country has become virtually impossible. Furthermore, the crisis will undoubtedly lead to large reductions in performance of some QIP measures in the short-and medium-term. However, CMS still has not announced further postponements to QIP reporting. As previously discussed, AVFs and AVGs have undergone substantial delays, which will inevitably affect quality measures regarding vascular access.

Because AVFs can take six months or longer to mature, CMS should anticipate poor performance beyond the COVID-19 pandemic and should consider delaying evaluation of vascular access measures even after the crisis has abated. Likewise, delays in transplant evaluations will impede facility performance on kidney transplant waitlist measures and reduce the overall transplantation rate. Eighty percent of deceased donor kidney transplant programs surveyed in the United States are operating with some restrictions 63, 64 . Regional variability in COVID-19 emergency room and hospitalizations rates will also unpredictably change the standardized hospitalization and readmission ratios 65 . Given the rapidly evolving crisis, CMS should closely monitor vascular access outcomes, transplantations, and hospitalization rates alongside COVID-19 cases, so it can determine when and how the QIP can be appropriately reinstated.

The COVID-19 pandemic has brought unprecedented challenges to the delivery of healthcare to patients with ESKD. Policy and healthcare infrastructure have been transformed in response to these challenges and include strategies for resource management, an expansion of telemedicine and home dialysis modalities, refined guidance on dialysis access procedures, extra measures to relieve administrative burden, and a re-evaluation of quality metrics.

Continued exploration of creative ways to implement dialysis access procedures, telemedicine, and home dialysis modalities are particularly relevant for emergency preparedness in the future.

Other key issues include optimizing patient education, infection control and access to transportation. Key themes in the response to the COVID-19 pandemic are flexibility of policy, clear strategies for emergency preparedness, and robust health systems that maximize accessibility and patient autonomy. 

Covid-19: risk factors for severe disease and death

Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study

Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis

COVID-19 and dialysis: why we should be worried

On the Frontline of the COVID-19 Outbreak: Keeping Patients on Long-Term Dialysis Safe

Food and Drug Administration. FDA Drug Shortages

Shortage of Dialysis Equipment Leads to Difficult Decisions in New York ICUs

Doctors at Hard-Hit Hospitals Say They're Facing Shortage of Dialysis Equipment

Strategies to Mitigate Healthcare Personnel Staffing Shortages

Considerations for Alternate Care Sites

Criteria for Return to Work for Healthcare Personnel with Suspected or Confirmed COVID-19 (Interim Guidance)

Strategies to Optimize the Supply of PPE and Equipment

A pandemic influenza preparedness study: Use of energetic methods to decontaminate filtering facepiece respirators contaminated with H1N1 aerosols and droplets

Evaluation of Five Decontamination Methods for Filtering Facepiece Respirators

Decontamination and Reuse of N95 Respirators with Hydrogen Peroxide Vapor to Address Worldwide Personal Protective Equipment Shortages During the SARS-CoV-2 (COVID-19) Pandemic

Final Report for the Bioquell Hydrogen Peroxide Vapor (HPV) Decontamination for Reuse of N95 Respirators

COVID-19 global pandemic planning: Decontamination and reuse processes for N95 respirators

Virtually Perfect? Telemedicine for Covid-19

Medicare Telehealth Services and Nephrology: Policies for Eligibility and Payment

Physicians and Other Clinicians: CMS Flexibilities to Fight COVID-19

Targeting Access to Kidney Care Via Telehealth: The VA Experience

Nephrology and Telehealth: Now? or Now! Adv Chronic Kidney Dis

General Guidance on Deferring Non-Urgent CV Testing and Procedures During the COVID-19 Pandemic. Cardiol Mag

Emerging Practice Patterns in Vascular Surgery During the COVID-19 Pandemic

Perspectives on vascular surgical practice change due to COVID-19 at a nonacademic tertiary care center

Critical clarification from CMS: PD catheter and vascular access placement is essential

Controlled Trial of Early versus Late Initiation of Dialysis

Do Not Delay Urgent Medical Care Due to the COVID-19 Coronavirus Pandemic

Collateral damage of COVID-19 pandemic: Delayed medical care

Delayed Diagnosis of Pediatric Appendicitis during the COVID-19 Pandemic

Urology in the Time of Coronavirus: Reduced Access to Urgent and Emergent Urological Care during the Coronavirus Disease

Hemodialysis Catheter-Related Central Venous Thrombosis: Clinical Approach to Evaluation and Management

Natural History of Tunneled Dialysis Catheters Placed for Hemodialysis Initiation

Management of the Hemodialysis Patient with Catheter-Related Bloodstream Infection

Elective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plans: Elective surgery during the SARS-CoV-2 pandemic

Local Resumption of Elective Surgery Guidance

Historic financial decline hits doctors, dentists and hospitals -despite COVID-19 -threatening overall economy

Surgical wait list management in Canada during a pandemic: many challenges ahead

Place of Percutaneous Fistula Devices in Contemporary Management of Vascular Access

A Review of the Current Status of Percutaneous Endovascular Arteriovenous Fistula Creation for Haemodialysis Access

Department of Health and Human Services

A Call to Action for the Kidney Community: Nephrologists' Perspective on Advancing American Kidney Health

US Renal Data System 2019 Annual Report: Epidemiology of Kidney Disease in the United States

At Home: Considerations in the Care of Patients Receiving Home Dialysis During the COVID-19 Pandemic: A Statement from the ASN COVID-19 Response Team

Operationalizing Telehealth for Home Dialysis Patients in the United States

End Stage Renal Disease (ESRD) Facilities: CMS Flexibilities to Fight COVID-19

Guidance for Infection Control and Prevention of Coronavirus Disease 2019 (COVID-19) in dialysis facilities

High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study

COVID-19 and the Inpatient Dialysis Unit: Managing Resources during Contingency Planning Pre-Crisis

Kidney involvement in COVID-19 and rationale for extracorporeal therapies

Programs; Regulatory Provisions to Promote Program Efficiency, Transparency, and Burden Reduction; Fire Safety Requirements for Certain Dialysis Facilities; Hospital and Critical Access Hospital (CAH) Changes to Promote Innovation, Flexibility, and Improvment in Patient Care

COVID-19 Emergency Declaration Blanket Waivers for Health Care Providers

Four years into MACRA: What has changed? Semin Dial

The Medicare Access and CHIP Reauthorization Act: Implications for Nephrology

Quality Payment Program -COVID-19 Response

CMS Announces Relief for Clinicians, Providers, Hospitals and Facilities Participating in Quality Reporting Programs in Response to COVID-19

Freestanding Dialysis Facility Quality Incentive Program Scores and Mortality Among Incident Dialysis Patients in the United States

Early impact of COVID-19 on transplant center practices and policies in the United States

COVID-19 In Spain: Transplantation In The Midst Of The Pandemic

COVID-19 United States Cases by County